Indian
Passengers avoid SpiceJet after mid-air safety failures: Survey
In a rare occurence, India’s aviation regulator on Wednesday said...
Need to ensure 100% renewables alongside electric vehicles to tackle climate crisis: Experts
''Changes in transport need to go hand in hand with changes in the...
Coal pensioners’ body writes to PM Modi, seeks revision of post-retirement benefits
''We have written to the Prime Minister on July 5 on behalf of the...
Life insurance premiums rise by 40% to Rs 73,674 crore in Q1 Fy 2022-23
Recently listed LIC posted a 35.39 per cent growth in its new...
International
BMS launches ASIA operations
“We will look to expand out from M&A insurance into additional specialisms, extending our existing areas of expertise into other sectors, potentially including reinsurance, renewable energy, marine, and capital markets. We hope our ambition and entrepreneurial culture will continue to attract the very best talent in the market,”said Nick Cook, CEO of BMS Group
Global Covid-19 cases surpass 85 million mark: Johns Hopkins University
The US is the worst-hit country with the world’s highest number of cases and deaths at 20,626,686 and 351,453, respectively, according to the CSSE.
India comes in second place in terms of cases at 10,323,965, while the country’s death toll soared to 149,435.
Brazil currently accounts for the second highest number of fatalities at 196,018.
1 Jan renewals:Reinsurers arrest downward pricing, say no to ongoing Contagious Disease exposures
Improving investment markets, retained earnings and newly raised capital helped global reinsurance capital levels to recover rapidly during 2020, ending the year 3% higher than at year-end 2019.
For buyers, terms and conditions have overall been less onerous than initially feared again revealing the efficient working of the global reinsurance market,
Emerging COVID-19 losses, often advised only late in the renewal process or yet to be advised, triggered technical discussions of primary policy coverage and reinsurance treaty wordings.
Both remain in the early stages of deliberation, so, sensibly, most programmes renewed without considering any potential COVID-19 losses, leaving time for more measured discussions and subsequent adjustments.
Germany mulls delaying second COVID-19 vaccine shot, Denmark approves delay
Some German health experts have welcomed Britain’s move to delay administering a second dose of the BioNTech/Pfizer shot, which comes as governments try to provide protection against coronavirus to as many people as possible by giving them one shot and delaying a second.
However, BioNTech and Pfizer pointed in a joint statement to a lack of trial data to support delaying the second dose.
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Advertisement
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
